{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:32:38Z","timestamp":1759159958149,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00705-017-3666-9","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T07:51:46Z","timestamp":1513669906000},"page":"867-876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vivo-morpholino oligomers strongly inhibit dengue virus replication and production"],"prefix":"10.1007","volume":"163","author":[{"given":"Patta","family":"Phumesin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutita","family":"Junking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aussara","family":"Panya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petlada","family":"Yongpitakwattana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sansanee","family":"Noisakran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thawornchai","family":"Limjindaporn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-5927","authenticated-orcid":false,"given":"Pa-thai","family":"Yenchitsomanus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"3666_CR1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI (2013) The global distribution and burden of dengue. Nature 496:504\u2013507","journal-title":"Nature"},{"key":"3666_CR2","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","volume":"384","author":"MR Capeding","year":"2014","unstructured":"Capeding MR, Tran NH, Hadinegoro SR, Ismail HI, Chotpitayasunondh T, Chua MN, Luong CQ, Rusmil K, Wirawan DN, Nallusamy R, Pitisuttithum P, Thisyakorn U, Yoon IK, van der Vliet D, Langevin E, Laot T, Hutagalung Y, Frago C, Boaz M, Wartel TA, Tornieporth NG, Saville M, Bouckenooghe A, Group CYDS (2014) Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384:1358\u20131365","journal-title":"Lancet"},{"key":"3666_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12985-014-0219-7","volume":"12","author":"T Dechtawewat","year":"2015","unstructured":"Dechtawewat T, Songprakhon P, Limjindaporn T, Puttikhunt C, Kasinrerk W, Saitornuang S, Yenchitsomanus PT, Noisakran S (2015) Role of human heterogeneous nuclear ribonucleoprotein C1\/C2 in dengue virus replication. Virol J 12:14","journal-title":"Virol J"},{"key":"3666_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.virol.2005.08.034","volume":"344","author":"KL Holden","year":"2006","unstructured":"Holden KL, Stein DA, Pierson TC, Ahmed AA, Clyde K, Iversen PL, Harris E (2006) Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3\u2019 stem-loop structure. Virology 344:439\u2013452","journal-title":"Virology"},{"key":"3666_CR5","unstructured":"http:\/\/www.who.int\/immunization\/research\/development\/dengue_vaccines\/"},{"key":"3666_CR6","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.1128\/JVI.02774-12","volume":"87","author":"PK Kakumani","year":"2013","unstructured":"Kakumani PK, Ponia SS, Rajgokul KS, Sood V, Chinnappan M, Banerjea AC, Medigeshi GR, Malhotra P, Mukherjee SK, Bhatnagar RK (2013) Role of RNA interference (RNAi) in dengue virus replication and identification of NS4B as an RNAi suppressor. J Virol 87:8870\u20138883","journal-title":"J Virol"},{"key":"3666_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2016.06.002","volume":"30","author":"SJ Kaptein","year":"2016","unstructured":"Kaptein SJ, Neyts J (2016) Towards antiviral therapies for treating dengue virus infections. Curr Opin Pharmacol 30:1\u20137","journal-title":"Curr Opin Pharmacol"},{"key":"3666_CR8","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1128\/JVI.79.8.5116-5128.2005","volume":"79","author":"RM Kinney","year":"2005","unstructured":"Kinney RM, Huang CY, Rose BC, Kroeker AD, Dreher TW, Iversen PL, Stein DA (2005) Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers. J Virol 79:5116\u20135128","journal-title":"J Virol"},{"key":"3666_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.addr.2007.09.002","volume":"60","author":"B Lebleu","year":"2008","unstructured":"Lebleu B, Moulton HM, Abes R, Ivanova GD, Abes S, Stein DA, Iversen PL, Arzumanov AA, Gait MJ (2008) Cell penetrating peptide conjugates of steric block oligonucleotides. Adv Drug Deliv Rev 60:517\u2013529","journal-title":"Adv Drug Deliv Rev"},{"key":"3666_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.bbrc.2016.07.029","volume":"478","author":"SL Leela","year":"2016","unstructured":"Leela SL, Srisawat C, Sreekanth GP, Noisakran S, Yenchitsomanus PT, Limjindaporn T (2016) Drug repurposing of minocycline against dengue virus infection. Biochem Biophys Res Commun 478:410\u2013416","journal-title":"Biochem Biophys Res Commun"},{"key":"3666_CR11","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1021\/bc8001437","volume":"19","author":"YF Li","year":"2008","unstructured":"Li YF, Morcos PA (2008) Design and synthesis of dendritic molecular transporter that achieves efficient in vivo delivery of morpholino antisense oligo. Bioconjug Chem 19:1464\u20131470","journal-title":"Bioconjug Chem"},{"key":"3666_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","volume":"14","author":"JG Low","year":"2014","unstructured":"Low JG, Sung C, Wijaya L, Wei Y, Rathore AP, Watanabe S, Tan BH, Toh L, Chua LT, Hou Y, Chow A, Howe S, Chan WK, Tan KH, Chung JS, Cherng BP, Lye DC, Tambayah PA, Ng LC, Connolly J, Hibberd ML, Leo YS, Cheung YB, Ooi EE, Vasudevan SG (2014) Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis 14:706\u2013715","journal-title":"Lancet Infect Dis"},{"key":"3666_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jama.280.10.871-JMN0909-6-1","volume":"280","author":"C Marwick","year":"1998","unstructured":"Marwick C (1998) First \u201cantisense\u201d drug will treat CMV retinitis. JAMA 280:871","journal-title":"JAMA"},{"key":"3666_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2144\/000113005","volume":"45","author":"PA Morcos","year":"2008","unstructured":"Morcos PA, Li Y, Jiang S (2008) Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues. Biotechniques 45:613\u2013614, 616, 618 passim","journal-title":"Biotechniques"},{"key":"3666_CR15","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3390\/molecules14031304","volume":"14","author":"JD Moulton","year":"2009","unstructured":"Moulton JD, Jiang S (2009) Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules 14:1304\u20131323","journal-title":"Molecules"},{"key":"3666_CR16","doi-asserted-by":"publisher","first-page":"e892","DOI":"10.1371\/journal.pntd.0000892","volume":"4","author":"A Nazmi","year":"2010","unstructured":"Nazmi A, Dutta K, Basu A (2010) Antiviral and neuroprotective role of octaguanidinium dendrimer-conjugated morpholino oligomers in Japanese encephalitis. PLoS Negl Trop Dis 4:e892","journal-title":"PLoS Negl Trop Dis"},{"key":"3666_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/cbdd.12309","volume":"84","author":"A Panya","year":"2014","unstructured":"Panya A, Bangphoomi K, Choowongkomon K, Yenchitsomanus PT (2014) Peptide inhibitors against dengue virus infection. Chem Biol Drug Des 84:148\u2013157","journal-title":"Chem Biol Drug Des"},{"key":"3666_CR18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/cbdd.12576","volume":"86","author":"A Panya","year":"2015","unstructured":"Panya A, Sawasdee N, Junking M, Srisawat C, Choowongkomon K, Yenchitsomanus PT (2015) A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Chem Biol Drug Des 86:1093\u20131104","journal-title":"Chem Biol Drug Des"},{"key":"3666_CR19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4161\/mabs.27874","volume":"6","author":"O Poungpair","year":"2014","unstructured":"Poungpair O, Bangphoomi K, Chaowalit P, Sawasdee N, Saokaew N, Choowongkomon K, Chaicumpa W, Yenchitsomanus PT (2014) Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycle. MAbs 6:474\u2013482","journal-title":"MAbs"},{"key":"3666_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.antiviral.2015.10.005","volume":"124","author":"T Rattanaburee","year":"2015","unstructured":"Rattanaburee T, Junking M, Panya A, Sawasdee N, Songprakhon P, Suttitheptumrong A, Limjindaporn T, Haegeman G, Yenchitsomanus PT (2015) Inhibition of dengue virus production and cytokine\/chemokine expression by ribavirin and compound A. Antiviral Res 124:83\u201392","journal-title":"Antiviral Res"},{"key":"3666_CR21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1128\/JVI.69.1.69-74.1995","volume":"69","author":"K Raviprakash","year":"1995","unstructured":"Raviprakash K, Liu K, Matteucci M, Wagner R, Riffenburgh R, Carl M (1995) Inhibition of dengue virus by novel, modified antisense oligonucleotides. J Virol 69:69\u201374","journal-title":"J Virol"},{"key":"3666_CR22","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","volume":"380","author":"A Sabchareon","year":"2012","unstructured":"Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, Dulyachai W, Pengsaa K, Wartel TA, Moureau A, Saville M, Bouckenooghe A, Viviani S, Tornieporth NG, Lang J (2012) Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 380:1559\u20131567","journal-title":"Lancet"},{"key":"3666_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/lam.12186","volume":"58","author":"N Saokaew","year":"2014","unstructured":"Saokaew N, Poungpair O, Panya A, Tarasuk M, Sawasdee N, Limjindaporn T, Chaicumpa W, Yenchitsomanus P (2014) Human monoclonal single-chain antibodies specific to dengue virus envelope protein. Lett Appl Microbiol 58:270\u2013277","journal-title":"Lett Appl Microbiol"},{"key":"3666_CR24","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1039\/C4MD00184B","volume":"5","author":"VK Sharma","year":"2014","unstructured":"Sharma VK, Sharma RK, Singh SK (2014) Antisense oligonucleotides: modifications and clinical trials. Medchemcomm 5:1454\u20131471","journal-title":"Medchemcomm"},{"key":"3666_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/jac\/dkn221","volume":"62","author":"DA Stein","year":"2008","unstructured":"Stein DA, Huang CY, Silengo S, Amantana A, Crumley S, Blouch RE, Iversen PL, Kinney RM (2008) Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus. J Antimicrob Chemother 62:555\u2013565","journal-title":"J Antimicrob Chemother"},{"key":"3666_CR26","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1128\/JVI.02105-08","volume":"84","author":"S Subramanya","year":"2010","unstructured":"Subramanya S, Kim SS, Abraham S, Yao J, Kumar M, Kumar P, Haridas V, Lee SK, Shultz LD, Greiner D, Manjunath N, Shankar P (2010) Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. J Virol 84:2490\u20132501","journal-title":"J Virol"},{"key":"3666_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bbrc.2013.05.094","volume":"436","author":"A Suttitheptumrong","year":"2013","unstructured":"Suttitheptumrong A, Khunchai S, Panaampon J, Yasamut U, Morchang A, Puttikhunt C, Noisakran S, Haegeman G, Yenchitsomanus PT, Limjindaporn T (2013) Compound A, a dissociated glucocorticoid receptor modulator, reduces dengue virus-induced cytokine secretion and dengue virus production. Biochem Biophys Res Commun 436:283\u2013288","journal-title":"Biochem Biophys Res Commun"},{"key":"3666_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.antiviral.2014.04.004","volume":"107","author":"CW Tan","year":"2014","unstructured":"Tan CW, Chan YF, Quah YW, Poh CL (2014) Inhibition of enterovirus 71 infection by antisense octaguanidinium dendrimer-conjugated morpholino oligomers. Antiviral Res 107:35\u201341","journal-title":"Antiviral Res"},{"key":"3666_CR29","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.1371\/journal.pntd.0000785","volume":"4","author":"V Tricou","year":"2010","unstructured":"Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, Wills B, Tran HT, Simmons CP (2010) A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis 4:e785","journal-title":"PLoS Negl Trop Dis"},{"key":"3666_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1086\/315215","volume":"181","author":"DW Vaughn","year":"2000","unstructured":"Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181:2\u20139","journal-title":"J Infect Dis"},{"key":"3666_CR31","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/AAC.01148-08","volume":"53","author":"QY Wang","year":"2009","unstructured":"Wang QY, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, Schul W, Gu F, Heudi O, Ma NL, Poh MK, Phong WY, Keller TH, Jacoby E, Vasudevan SG (2009) A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother 53:1823\u20131831","journal-title":"Antimicrob Agents Chemother"},{"key":"3666_CR32","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jinf.2014.12.001","volume":"70","author":"W Wen","year":"2015","unstructured":"Wen W, He Z, Jing Q, Hu Y, Lin C, Zhou R, Wang X, Su Y, Yuan J, Chen Z, Yuan J, Wu J, Li J, Zhu X, Li M (2015) Cellular microRNA-miR-548g-3p modulates the replication of dengue virus. J Infect 70:631\u2013640","journal-title":"J Infect"},{"key":"3666_CR33","doi-asserted-by":"publisher","first-page":"20435","DOI":"10.1073\/pnas.0907010106","volume":"106","author":"Z Yin","year":"2009","unstructured":"Yin Z, Chen YL, Schul W, Wang QY, Gu F, Duraiswamy J, Kondreddi RR, Niyomrattanakit P, Lakshminarayana SB, Goh A, Xu HY, Liu W, Liu B, Lim JY, Ng CY, Qing M, Lim CC, Yip A, Wang G, Chan WL, Tan HP, Lin K, Zhang B, Zou G, Bernard KA, Garrett C, Beltz K, Dong M, Weaver M, He H, Pichota A, Dartois V, Keller TH, Shi PY (2009) An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci USA 106:20435\u201320439","journal-title":"Proc Natl Acad Sci USA"},{"key":"3666_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/hum.2012.211","volume":"24","author":"H Zhou","year":"2013","unstructured":"Zhou H, Janghra N, Mitrpant C, Dickinson RL, Anthony K, Price L, Eperon IC, Wilton SD, Morgan J, Muntoni F (2013) A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice. Hum Gene Ther 24:331\u2013342","journal-title":"Hum Gene Ther"},{"issue":"1","key":"3666_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbrc.2017.01.006","volume":"483","author":"T Limjindaporn","year":"2017","unstructured":"Limjindaporn T, Panaampon J, Malakar S, Noisakran S, Yenchitsomanus PT (2017) Tyrosine kinase\/phosphatase inhibitors decrease dengue virus production in HepG2 cells. Biochem Biophys Res Commun. 483(1):58\u201363","journal-title":"Biochem Biophys Res Commun."}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-017-3666-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3666-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3666-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T13:41:14Z","timestamp":1603546874000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-017-3666-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3666"],"URL":"https:\/\/doi.org\/10.1007\/s00705-017-3666-9","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"type":"print","value":"0304-8608"},{"type":"electronic","value":"1432-8798"}],"subject":[],"published":{"date-parts":[[2017,12,19]]},"assertion":[{"value":"2 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The use of human peripheral blood mononuclear cells (PBMCs) from healthy donors was ethically approved by the Siriraj Institutional Review Board, Faculty of Medicine Siriraj Hospital, Mahidol University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}